Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease

被引：0
|
作者：
Stephen J. Nicholls
Kausik K. Ray
Jan O. Johansson
Alan Gordon
Michael Sweeney
Chris Halliday
Ewelina Kulikowski
Norman Wong
Susan W. Kim
Gregory G. Schwartz
机构：
[1] University of Adelaide,South Australian Health and Medical Research Institute
[2] Imperial College London,School of Public Health
[3] Resverlogix Corporation,undefined
[4] University of Colorado School of Medicine,undefined
来源：
American Journal of Cardiovascular Drugs | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 115
页数：6
相关论文
共 50 条
  • [1] Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease
    Nicholls, Stephen J.
    Ray, Kausik K.
    Johansson, Jan O.
    Gordon, Alan
    Sweeney, Michael
    Halliday, Chris
    Kulikowski, Ewelina
    Wong, Norman
    Kim, Susan W.
    Schwartz, Gregory G.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (02) : 109 - 115
  • [2] Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes
    Brandts, Julia
    Ray, Kausik K.
    FUTURE CARDIOLOGY, 2020, 16 (05) : 385 - 395
  • [3] Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes
    Ray, K. K.
    Nicholls, S. J.
    Buhr, K. A.
    Ginsberg, H. N.
    Kalantar-Zadeh, K.
    Johansson, J. O.
    Kulikowski, E.
    Toth, P. P.
    Wong, N.
    Sweeney, M.
    Schwartz, G. G.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1425 - 1425
  • [4] Effect of BET Protein Inhibition With Apabetalone on Cardiovascular Outcomes in Patients With Acute Coronary Syndrome and Diabetes - Results of the BETonMACE Trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Ginsberg, Henry N.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Sweeney, Michael
    Schwartz, Gregory G.
    CIRCULATION, 2019, 140 (25) : E966 - E966
  • [5] Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial
    Ray, Kausik K.
    Nicholls, Stephen J.
    Ginsberg, Henry D.
    Johansson, Jan O.
    Kalantar-Zadeh, Kamyar
    Kulikowski, Ewelina
    Toth, Peter P.
    Wong, Norman
    Cummings, Jeffrey L.
    Sweeney, Michael
    Schwartz, Gregory G.
    AMERICAN HEART JOURNAL, 2019, 217 : 72 - 83
  • [6] Plasma triglycerides and cardiovascular events in the TNT and IDEAL trials of statins in patients with coronary artery disease
    Faergeman, O.
    Holme, I.
    Larosa, J. C.
    Waters, D. D.
    Olsson, A. G.
    Fayyad, R.
    Kastelein, J. J. P.
    EUROPEAN HEART JOURNAL, 2008, 29 : 346 - 346
  • [7] APABETALONE, A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES SERUM FGF23 IN CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE PATIENTS
    Kalantar-Zadeh, Kamyar
    Zoccali, Carmine
    Beddhu, Srinivasan
    Brandenburg, Vincent
    Haarhaus, Mathias
    Tonelli, Marcello
    Khan, Aziz
    Halliday, Christopher
    Lebioda, Ken
    Johansson, Jan O.
    Sweeney, Michael
    Wong, Norman C. W.
    Kulikowski, Ewelina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [8] Anemia predicts cardiovascular events in patients with coronary artery disease
    Asselbergs, FW
    Van der Meer, P
    Tio, RA
    Lipsic, E
    Van Veldhuisen, DJ
    Van Gilst, WH
    Zijlstra, F
    EUROPEAN HEART JOURNAL, 2004, 25 : 498 - 499
  • [9] Selenium concentration and cardiovascular events in patients with coronary artery disease
    Sinning, Christoph R.
    Lubos, Edith
    Schnalbel, Renate
    Sinning, Jan-Malte
    Wild, Philipp S.
    Zeller, Tanja
    Bickel, Christoph
    Espinoia-Klein, Christine
    Lackner, Karl J.
    Tiret, Laurence
    Muenzel, Thomas F.
    Blankenberg, Stefan
    CIRCULATION, 2007, 116 (16) : 842 - 843
  • [10] Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials
    Lee, E.
    Tan, B.
    Chin, Y. H.
    Chan, Y. H.
    Ong, J.
    Goh, R. S. J.
    Chong, B.
    Anand, V. V.
    Kong, G.
    Wang, J. W.
    Muthiah, M. D.
    Loh, P. H.
    Chan, M. Y.
    Chew, N. W. S.
    Mamas, M. A.
    EUROPEAN HEART JOURNAL, 2024, 45
12345